Trident Lifeline Ltd

Fri 4/09/2026,15:26:0 | BSE : TLL

₹294.0021.30 (7.81%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 279.00

Previous Close

₹ 272.70

Volume

37200

Mkt Cap ( ₹ Cr)

₹ 346.86

High

₹ 301.00

Low

₹ 275.10

52 Week High

₹ 328.00

52 Week Low

₹ 229.95

Book Value Per Share

₹ 86.12

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Trident Lifeline Ltd

Your Vote -

Buy

25.00%

Hold

50.00%

Sell

25.00%

25.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Trident Lifeline Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Trident Lifeline - Reg. 34 (1) Annual Report.

    4 Sep 2026, 12:46PM Annual Report for FY 2025-26
  • Trident Lifeline - Notice Of 13Th Annual General Meeting Of The Company

    4 Sep 2026, 12:37PM The 13th Annual General Meeting (\AGM\) of the Company will be held on Saturday, September 26, 2026 at 04:00 p.m. IST through Video Conferencing / Oth
  • Trident Lifeline - Revision Of Book Closure And Cut-Off Date For The 13Th Annual General Meeting

    4 Sep 2026, 12:16PM The Book Closure period and Cut-off date for remote e-voting and e-voting during the AGM shall stand revised as under:\r\n\r\nBook Closure: Sunday, Se
  • Trident Lifeline - Announcement under Regulation 30 (LODR)-Allotment

    31 Aug 2026, 5:21PM Allotment of 24000 Shares upon convserion of Warrants into Equity
  • Trident Lifeline - Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. On August 31, 2026, In Terms Of Seco

    31 Aug 2026, 5:18PM Allotment of 24000 Equity Shares of Rs. 10/- each upon conversion/ exchange of equal number of warrants
  • Trident Lifeline - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirement) Regulations, 2015-

    31 Aug 2026, 1:54PM In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has been
  • Trident Lifeline - Intimation Of Book Closure And Cut-Off Date For 13Th AGM

    26 Aug 2026, 6:42PM Pursuant to section 91 of Companies Act, 2013 and Regulation 42 of SEBI (LODR) Regulation, 2015, the Register of Members and Share Transfer books of t
  • Trident Lifeline - 13Th Annual General Meeting Scheduled To Be Held On 26.09.2026

    26 Aug 2026, 6:40PM 13th Annual General Meeting ('AGM') of the Members of Trident Lifeline Limited scheduled to be held on Saturday, September 26, 2026 at 04:00 p.m. thro
  • Trident Lifeline - Outcome Of Board Meeting Held On 26.08.2026

    26 Aug 2026, 6:34PM Outcome of Board Meeting held on 26.08.2026
  • Trident Lifeline - Board Meeting Outcome for Outcome Of Board Meeting Held On 26.08.2026

    26 Aug 2026, 6:32PM Outcome of Board Meeting held on 26.08.2026
  • Trident Lifeline - Announcement Under Regulation 30(LODR)-Trident Lifeline Limited Featured In India Pharma Outlook Magazine

    22 Aug 2026, 11:44AM Announcement under Regulation 30 (LODR)-Trident Lifeline Limited featured in India Pharma Outlook Magazine
  • Trident Lifeline - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirement) Regulations, 2015-

    20 Aug 2026, 6:59PM With reference to the above-captioned subject, we are pleased to inform you that the Company has been honoured with the prestigious award under the ca
  • Trident Lifeline - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    20 Aug 2026, 6:55PM Outcome of Analyst/Institutional Investor Meeting
  • Trident Lifeline - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    17 Aug 2026, 3:24PM Pursuant to the requirements of Regulation 30 of the Securities Exchange Board of India (Listing obligation and Disclosure Requirements) Regulations,
  • Trident Lifeline - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirement) Regulations, 2015-

    17 Aug 2026, 3:16PM In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform you that the company is select
  • Trident Lifeline - Announcement under Regulation 30 (LODR)-Investor Presentation

    3 Aug 2026, 3:27PM Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Earnings Presenta
  • Trident Lifeline - Result- Financial Result For Quarter Ended 30.06.2026

    29 Jul 2026, 8:49PM The Board of Directors inter-alia has approved and taken on record Un-Audited Standalone and Consolidated Financial Results for the quarter ended June
  • Trident Lifeline - Board Meeting Outcome for Outcome Of Board Meeting Held On 29.07.2026

    29 Jul 2026, 8:37PM Outcome of Board Meeting held on 29.07.2026
  • Trident Lifeline - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone & C

    24 Jul 2026, 11:15AM Trident Lifeline Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 ,inter alia, to consider and
  • Trident Lifeline - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    17 Jul 2026, 2:22PM With reference to captioned subject, we are enclosing herewith Voting Result and scrutinizer Report. \r\n\r\nPlease take the same on your records.
  • Trident Lifeline - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    17 Jul 2026, 12:02PM With reference to captioned subject, we are enlcosing herewith voting Result along with Scrutinzer Report. \r\n\r\nPlease take the same on your record
  • Trident Lifeline has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    14 Jul 2026, 1:41PM As of June 2026, 62.59% is owned by Promoters and 37.41% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 62.04% and Forei
  • Trident Lifeline - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    10 Jul 2026, 3:42PM Please find enclosed herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 as received from MUFG I
  • Trident Lifeline - Announcement under Regulation 30 (LODR)-Acquisition

    16 Jun 2026, 6:00PM We wish to inform to the Exchange that TRIDENT MEDIQUIP LIMITED (TML) (CIN: U33309GJ2019PLC110421), a subsidiary company has made Private Placement of
  • Trident Lifeline - Announcement under Regulation 30 (LODR)-Acquisition

    9 Jun 2026, 3:31PM We wish to inform to the Exchange that TRIDENT MEDIQUIP LIMITED (TML) (CIN: U33309GJ2019PLC110421), a subsidiary company has made Private Placement of

Key fundamentals

Evaluate the intrinsic value of Trident Lifeline Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 123.6794 80.6215 58.8707 49.0094 7.2556
Liabilities 123.6794 80.6215 58.8707 49.0094 7.2556
Equity 11.933 11.4992 11.4992 11.4992 8
Gross Profit 24.33 17.5219 8.8297 6.2509 2.7613
Net Profit 18.0927 13.0514 7.0434 6.012 2.2732
Cash From Operating Activities 7.9319 -3.4931 0.8953 -16.6037 -0.2521
NPM(%) 17.75 19.25 15.77 18.96 10.44
Revenue 101.8995 67.7991 44.6524 31.6922 21.7679
Expenses 77.5695 50.2772 35.8227 25.4413 19.0066
ROE(%) 17.8 12.84 6.93 5.91 2.23

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Trident Lifeline Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 863.00 -0.52 21.76 167.39 -26.19 0.58
Lotus Eye Hospital and Institute Ltd 109.90 -0.68 1563.29 609.96 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 15.42 0.72 0.00 1266.47 -39.50 0.00
Astec Lifesciences Ltd 552.30 -3.93 0.00 653.53 -363.14 0.00

Company Info

Our Company was originally incorporated as "Trident Lifeline Private Limited" as a Private Limited Company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated January 09, 2014, issued by the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Subsequently, our Company was converted into a Public Limited Company pursuant to shareholders resolution passed at Extra-ordinary General Meeting of our Company held on June 02, 2022 and the name of our Company was changed to "Trident Lifeline Limited". A fresh Certificate of Incorporation consequent upon Conversion from Private Limited Company to Public Limited Company dated June 10, 2022 was issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of our Company is U51909GJ2014PLC078227.Our promoters and directors have a combined experience of more than 19 years in the pharmaceutical products, Bulk drugs. Driven by the passion for building an integrated pharmaceutical company, backed by their experience, our Promoters have been the pillars of our Company's growth and have built a strong value system for our Company. With their enriching experience and progressive thinking, we aim to continue to grow in the pharmaceutical and bulk drugs industry.Our Company is engaged in the pharmaceutical business ethical marketing in domestic as well as inernational market. We are also engaged in distribution of pharmaceutical products through third party distribution network. We offer wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan lisence. We operate in India as well as African, Latin American and East Indian Countries. We have our presence through registered products or products under registration in countries like Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanamar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, Venuzela.We deal in Capsules, Tablets, Liquid Ointment, Gel, Ice Gel, Mouthwash, Paste, Solution, Suspension, Drypowders and Toothpaste. Our product portfolio comprises of vide range of drugs like Anti Bacterial, Anti Diarrheal, Anti Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical and Non-steriodal anti-inflamatory drug (NSAIDS). Our product portfolio consists of 832 products, as on May 31, 2022. We operate under different brand names across the globe. As on May 31, 2022, we have 267 products registered in total 8 countries. As on May 31, 2022, total565 products are under process of registration in 11 countries, which shall boost the growth of our company.MAJOR EVENTS2014Our Company was incorporated as a private limited company under the name "Trident Lifeline Private Limited" Limited2021-Our Company had Certified its Quality Management System Under the Certificate ISO 9001:2015.-Exports to LATAM and CIS Countries. 2022 -Acquisition of TNS Pharma Pvt. Ltd. 2023-The Company has approved the acquisition of majority stake (i.e. 51%) in TLL Herbal Limited making it subsidiary of the Company. 2024 -Acquisition of TLL Herbal Ltd. -Acquisition of 18% equity in Tricorp-Trident Lifeline Limited has commenced the commercial production at Sachin, Surat.-The Company has completed acquisition of an additional 50.49% of total shareholding in TLL Parenterals Limited 

Our Company was originally incorporated as "Trident Lifeline Private Limited" as a Private Limited Company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated January 09, 2014, issued by the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Subsequently, our Company was converted into a Public Limited Company pursuant to shareholders resolution passed at Extra-ordinary General Meeting of our Company held on June 02, 2022 and the name of our Company was changed to "Trident Lifeline Limited". A fresh Certificate of Incorporation consequent upon Conversion from Private Limited Company to Public Limited Company dated June 10, 2022 was issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of our Company is U51909GJ2014PLC078227.Our promoters and directors have a combined experience of more than 19 years in the pharmaceutical products, Bulk drugs. Driven by the passion for building an integrated pharmaceutical company, backed by their experience, our Promoters have been the pillars of our Company's growth and have built a strong value system for our Company. With their enriching experience and progressive thinking, we aim to continue to grow in the pharmaceutical and bulk drugs industry.Our Company is engaged in the pharmaceutical business ethical marketing in domestic as well as inernational market. We are also engaged in distribution of pharmaceutical products through third party distribution network. We offer wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan lisence. We operate in India as well as African, Latin American and East Indian Countries. We have our presence through registered products or products under registration in countries like Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanamar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, Venuzela.We deal in Capsules, Tablets, Liquid Ointment, Gel, Ice Gel, Mouthwash, Paste, Solution, Suspension, Drypowders and Toothpaste. Our product portfolio comprises of vide range of drugs like Anti Bacterial, Anti Diarrheal, Anti Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical and Non-steriodal anti-inflamatory drug (NSAIDS). Our product portfolio consists of 832 products, as on May 31, 2022. We operate under different brand names across the globe. As on May 31, 2022, we have 267 products registered in total 8 countries. As on May 31, 2022, total565 products are under process of registration in 11 countries, which shall boost the growth of our company.MAJOR EVENTS2014Our Company was incorporated as a private limited company under the name "Trident Lifeline Private Limited" Limited2021-Our Company had Certified its Quality Management System Under the Certificate ISO 9001:2015.-Exports to LATAM and CIS Countries. 2022 -Acquisition of TNS Pharma Pvt. Ltd. 2023-The Company has approved the acquisition of majority stake (i.e. 51%) in TLL Herbal Limited making it subsidiary of the Company. 2024 -Acquisition of TLL Herbal Ltd. -Acquisition of 18% equity in Tricorp-Trident Lifeline Limited has commenced the commercial production at Sachin, Surat.-The Company has completed acquisition of an additional 50.49% of total shareholding in TLL Parenterals Limited 

Parent Organisation

Trident Lifeline Ltd.

Founded

09/01/2014

Managing Director

Mr.Shravan Harikrishna Patel

NSE Symbol

FAQ